ABSTRACT

Diabetes is a major evildoer behind the mortality in the world. Worldwide data on mortality, Prevalence, and Incidence demand the humankind to take genuine endeavors on this issue, Current investigations and statics have expounded diabetes as one of the most prevalent endocrine disorder throughout the world. Citrullus colocynthis Schrad (CCS) is one of the most widely recognized conventional plants utilized as a remedy against diabetes. It is well recognized by its hypoglycaemic effect, which is substantiated. This plant, the fruit is usually recognized for its wide scope of anti-diabetic uses as well as pharmaceutical and nutraceutical potential. A genuine effort without any bias and interest has been taken in this article which provides the clear and cosine worldwide clinical and regulatory data of CCS. This review also sums up the various proven antidiabetic potential of CCS along with the granted patents. The only objective behind this article is to provide a thought process and to give a new vision to present and future scientists, researchers, industries, and regulatory bodies on the potential of CCS in diabetes for the betterment of society by highlighting clinical and pre-clinical studies which contributed to support the concept. This paper concludes that CCS possesses a wide range of medicinal uses and has been well studied for its antidiabetic potential. Keywords: Citrullus colocynthis Schrad, Clinical Trials, Diabetes, Medicinal Parts, Patents, Herbal
Publication date: 01/12/2020

https://ijbpas.com/pdf/2020/December/MS_IJBPAS_2020_5282.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2020/9.12.5282